Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia

Annals of Hematology

Volumn 81, Issue 10, 2002, Pages 570-574

  Hofmann, W K ^a   Seipelt, G ^a   Langenhan, S ^b   Reutzel, R ^a   Schott, D ^c   Schoeffski, O ^d   Illiger, H J ^e   Hartmann, F ^f   Balleisen, L ^g   Franke, A ^h   Fiedler, F ⁱ   Huber, C ^j   Rasche, H ^k   Bergmann, L ^l   Ganser, A ^m   Pott, C ⁿ   Pasold, R ^o   Rudolph, C ^p   Ottmann, O G ^a   Gokbuget N ^a   Hoelzer, D ^a   more..

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Community Hospital ^*  (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Department of Hematology and Oncology   (Germany)

^f SAARLAND UNIVERSITY   (Germany)

^g Evangelic Hospital   (Germany)

^h Department of Diagnostic Radiology   (Germany)

ⁱ Department of Surgery   (Germany)

^j JOHANNES GUTENBERG UNIVERSITY   (Germany)

^k University of Kiel ^*  (Germany)

^l UNIVERSITY OF ULM   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

ⁿ UNIVERSITY OF KIEL   (Germany)

^o NONE   (Germany)

^p NONE   (Germany)

more..

Author keywords

Acute lymphoblastic leukemia; Granulocyte colony stimulating factor; High dose cytarabine; Neutropenia

Indexed keywords

CYTARABINE; CYTOTOXIC AGENT; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APPENDICITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLICULITIS; HEMATOPOIESIS; HERPES; HUMAN; IMMUNOPHENOTYPING; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUSITIS; MULTICENTER STUDY; MYALGIA; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; SKIN INFECTION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036946826     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0542-8     Document Type: Article

References (17)

1. Clarke V, Dunstan FD, Webb DK (1999) Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia. Med Pediatr Oncol 32:331-335
2. Elonen E, Jantunen E, Koistinen P, Koivunen E, Lehtinen M, Nousiainen T, Pelliniemi TT, Remes K, Sinisalo M, Timonen T, Volin L, Ruutu T (1996) G-CSF (Lenograstim) following chemotherapy in the induction treatment of acute lymphoblastic leukemia (ALL) in adults. A randomized study between early and delayed start (abstract). Blood 88 [Suppl 1]:213a
3. Geissler K, Koller E, Hubmann E, Niederwieser D, Hinterberger W, Geissler D, Kyrle P, Knobl P, Pabinger I, Thalhammer R, Schwarzinger I, Mannhalter C, Jaeger U, Heinz R, Linkesch W, Lechner K (1997) Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - a randomized phase-III study. Blood 90:590-596
4. Hoelzer D (1991) High-dose chemotherapy in adult acute lymphoblastic leukemia. Semin Hematol 28 [Suppl 4]:84-89
5. Hoelzer D (1994) Therapy and prognostic factors in adult acute lymphoblastic leukaemia. Baillieres Clin Haematol 7:299-320
6. Hoelzer D (1997) Hematopoietic growth factors - not whether, but when and where. N Engl J Med 336:1822-1824
7. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123-131
8. Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA (1998) A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 92:1556-1564
9. Laver J, Amylon M, Desai S, Link M, Schwenn M, Mahmoud H, Shuster J (1998) Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study. J Clin Oncol 16:522-526
10. Michel G, Landman-Parker J, Auclerc MF, Mathey C, Leblanc T, Legall E, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Auvrignon A, Berthou C, Bauduer F, Pautard B, Schneider P, Schaison G, Leverger G, Baruchel A (2000) Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. J Clin Oncol 18:1517-1524
11. Ohno R, Tomonaga M, Ohshima T, Masaoka T, Asou N, Oh H, Nishikawa K, Kanamaru A, Murakami H, Furusawa S (1993) A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group. Int J Hematol 58:73-81
12. Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G (1995) Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood 86:444-450
13. Sawada KI, Sato N, Kohno M, Hannda H, Yasukouchi T, Tanngo M, Hirayama A, Koike T (1995) Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen. Leuk Lymphoma 20:103-109
14. Soda H, Oka M, Fukuda M, Kinoshita A, Sakamoto A, Araki J, Fujino S, Itoh N, Watanabe K, Kanda T, Nakano M, Hara K (1996) Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer. Cancer Chemother Pharmacol 38:9-12
15. Torres Gomez A, Jimenez MA, Alvarez MA, Rodriguez A, Martin C, Garcia MJ, Flores R, Sanchez J, de la Torre MJ, Herrera C, Roman J, Gomez P, Martinez F (1994) Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation. A prospective randomized study. Ann Hematol 71:65-70
16. Vey N, Molnar S, Faucher C, Le CA, Stoppa AM, Viens P, Bouabdallah R, Camerlo J, Novakovitch G, Mannoni P (1994) Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery. Bone Marrow Transplant 14:779-782
17. Welte K, Reiter A, Mempel K, Pfetsch M, Schwab G, Schrappe M, Riehm H (1996) A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group. Blood 87:3143-3150